4//SEC Filing
Chopas James George 4
Accession 0001127602-25-017836
CIK 0001492422other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:09 PM ET
Size
4.7 KB
Accession
0001127602-25-017836
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Award
Common Stock
2025-06-18+6,250→ 54,205 total
Footnotes (1)
- [F1]This restricted stock unit was granted on June 18, 2025. The restricted stock unit will vest over a two-year period. Specifically, 50% of the restricted unit will vest on each of the one-year and two-year anniversaries of the grant date, contingent upon continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001836430
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:09 PM ET
- Size
- 4.7 KB